From Idea to Market: Ep 8 - Built to Run

Send us Fan MailWhat does it actually take to move a medical device from a working prototype to a product that can be built reliably at volume? In this episode of From Idea to Market, surgeons, founders, and attorneys describe the discipline that separates an approved device from a scalable company.Most medical device teams underestimate what happens after a prototype works. Manufacturing at scale is a different problem from manufacturing at all, and the assumption that the hard work is done once the device is validated tends to be the most expensive miscalculation in med tech. This episode unpacks the transition from a hand-tuned engineering project to a controlled, reproducible production system, and why the process itself, not the device, becomes the real product.Jared Foran of Forcast Orthopedics, Leo Whiteside, Marie-Isabelle Batthyány of XRSynergies, Charles Lawrie of FIOS Health, Charlie DeCook of Total Joint Specialists, attorney Emily Ast, and Simon Mifsud of Garland Surgical share what they have learned from inside this transition. The conversation covers ISO 13485, design for manufacturability, supplier qualification, the economics of hardware versus software, supply chain design as part of the device itself, the kinds of problems that only surface at volume, and the contract clauses that quietly determine whether a successful product remains a fair deal once it scales globally.If you build, fund, regulate, or use medical devices, this episode is for you. It is the part of innovation that gets the least attention and decides the most outcomes — the daily, unglamorous work of building systems reliable enough that the product performs the same way every time, no matter who is in the room.⏱️ Chapters:00:00 Why scaling production breaks medical devices02:57 Meet the founders, surgeons, and attorneys05:30 What design freeze means in medical devices06:46 Why the process becomes the product, not the device09:32 Bringing manufacturing partners in before design freeze12:18 The three-times rule of medical device development15:59 Quality, cost, and scalability at production scale18:02 Why hardware med tech is harder than software20:18 Designing surgical kits for real-world supply chains25:22 Problems that only emerge at production volume28:11 Why founders should titrate the speed of scale30:45 IP clauses and royalty timing for global products34:58 What scale really proves about a medical device companyListen to the AHF Podcast on your preferred platform:Buzzsprout: https://ahfpodcast.buzzsprout.comApple Podcasts: https://podcasts.apple.com/us/podcast/ahf-podcast/id1749521487Spotify: https://open.spotify.com/show/5CrGJyvRiQFTCU3FFFVvHcLinkedIn: https://www.linkedin.com/showcase/ahf-podcastYouTube: https://www.youtube.com/@anteriorhipfoundationHomepage: https://anteriorhipfoundation.comThis podcast is intended for educational and informational purposes only.The content discussed does not constitute medical advice and should not be used as a substitute for professional judgment. Clinicians should rely on their own training, experience, and clinical decision-making when applying information from this discussion.#AnteriorHipFoundation #AHFPodcast #FromIdeaToMarket #MedTech #MedicalDeviceDevelopment #ISO13485 #DesignForManufacturability #DFM #QualityManagementSystem #MedTechScaling #OrthopedicInnovation #SurgicalInnovation #MedicalDeviceManufacturing #MedTechFounders